Todos os estudos
RecrutamentoFASE3INTERVENCIONISTA

Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy

This study is for people aged 6 and over with Familial Mediterranean Fever (FMF) whose symptoms aren't fully controlled by colchicine, even at the highest dose. It tests a treatment called Anakinra, which targets specific inflammation. Instead of taking Anakinra every day, this trial explores if taking it only when a painful FMF attack starts, until symptoms improve, works well. This is for people who prefer not to take daily injections. The study will compare this 'on-demand' Anakinra approach (alongside daily colchicine) with taking pain relief medicines when an attack occurs (also alongside daily colchicine). The aim is to find out if this focused treatment can effectively manage FMF flare-ups.

Em resumo

Status
Recrutamento
Fase
FASE3
Patrocinador
Assistance Publique - Hôpitaux de Paris
Meta de inscrição
50
Iniciar
04 Jun 2024
Conclusão estimada
04 Dec 2026

Sobre o que é este estudo?

Familial Mediterranean Fever (FMF) is a lifelong condition that causes repeated episodes of fever, tummy pain, joint pain, or skin rashes. These are often called 'attacks' or 'flare-ups'. For many years, the main treatment has been a daily medicine called colchicine, which helps prevent these attacks. However, for about 1 to 2 out of every 10 people, colchicine doesn't fully control their FMF, and they continue to have painful flare-ups. These people are considered to have 'colchicine-resistant' FMF.

Recently, newer medicines called 'biologics' have become available for FMF, including one called Anakinra. These medicines work by calming down the part of the body's defence system that causes the inflammation in FMF. Usually, if recommended by a doctor, Anakinra is given as a daily injection. However, some people might not want to inject themselves every day, or they might have other concerns about long-term daily treatment.

This study is looking into a different way to use Anakinra for these difficult-to-treat FMF attacks. Instead of daily injections, it wants to see if taking Anakinra only when a painful FMF attack begins – and stopping once the attack has settled – can still be effective. This 'on-demand' approach could offer more flexibility. The trial will compare this on-demand Anakinra, alongside your usual daily colchicine, against taking standard pain relief medicines during an attack, also with daily colchicine. The goal is to find a good treatment option for those who struggle with ongoing FMF attacks and prefer not to take continuous daily injections.

Pontos principais

  • Tests 'on-demand' Anakinra for FMF attacks.
  • For those with FMF not fully controlled by colchicine.
  • Compares it to standard pain relief during attacks.
  • Aims for better control without daily biologic injections.
  • Participating means continuing daily colchicine.

Quem pode ser elegível?

To be able to join this study, you must be at least 6 years old and have a confirmed diagnosis of FMF. Your FMF must also be considered 'colchicine-resistant', meaning you still get FMF attacks at least once a month, even though you're taking the highest dose of colchicine your doctor recommends.

Importantly, this study is specifically for people who don't want to take the daily injections of Anakinra as a continuous treatment, but are open to taking it just when an attack starts. You also shouldn't have any ongoing infections, especially tuberculosis, or a history of getting infections very often. If you are pregnant or breastfeeding, or are already taking other specific anti-inflammatory biologic medicines, you won't be able to join.

Your study doctor will carefully check if these and other specific health requirements are met to make sure the study is safe and right for you.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Are you 6 years old or older?
  2. Do you have a confirmed diagnosis of FMF?
  3. Do you still get FMF attacks at least once a month even with daily colchicine?
  4. Are you unwilling to take daily biologic injections for FMF?
  5. Você não está grávida ou amamentando atualmente?
  6. Do you not have active tuberculosis or frequent severe infections?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you decide to participate, you will continue to take your daily colchicine as prescribed. You will then be randomly assigned to one of two groups: either the 'on-demand Anakinra' group or the 'pain relief' group. Your daily colchicine will continue in both cases. If you are in the 'on-demand Anakinra' group, you will take an Anakinra injection (100mg) once a day as soon as you feel an FMF attack starting. You will continue this daily injection until your symptoms are better, for a maximum of 7 days. If you are in the 'pain relief' group, you will take standard pain relief medicines as needed when an attack starts. The study will involve regular visits or check-ins with the study team to monitor your FMF attacks, how you're feeling, and any side effects. The total duration of your participation in the study will be decided by the study team, but generally, these types of studies run for several months.

Riscos e benefícios potenciais

Participating in this trial might offer you the potential benefit of better control over your FMF attacks, especially if your current treatment isn't fully effective. Taking Anakinra on demand could lead to fewer or less severe attacks, improving your quality of life. However, like all medicines, Anakinra can have side effects, such as reactions at the injection site or an increased risk of infections, although these are usually mild. The alternative group will use regular pain relief, which also carries potential side effects. It's important to weigh these carefully. Remember, you can choose to leave the study at any time, for any reason, without it affecting your usual medical care.

Localizações (1)

  • Service de Médecine interne Hopital Tenon
    Código postal verificado
    Paris, França· Recrutamento

Perguntas frequentes

What is Familial Mediterranean Fever (FMF)?

FMF is a genetic condition that causes repeated episodes of inflammation, leading to fever, tummy pain, joint pain, or skin rashes.

What does 'colchicine-resistant' mean?

It means your FMF attacks aren't fully controlled by colchicine, even when you're taking the highest dose your doctor recommends.

What is Anakinra?

Anakinra is a medicine that helps calm down inflammation in your body. It's given by injection.

Why is this study looking at 'on-demand' Anakinra?

This study wants to see if taking Anakinra only when an FMF attack happens, rather than every day, is still effective for people who prefer not to have daily injections.

Do I need to take daily colchicine if I join the study?

Yes, you will continue to take your daily colchicine throughout the study, whichever group you are in.

Como saber mais

Léa SAVEY

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "Randomized Controlled Trial in Patients on Long-term Colchic…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.